| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2024 | Option Exercise | $28.80 | 3,656 | 105,293 | 46,617 | Feb 13, 2024, 05:38 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 02, 2024 | Option Exercise | $11.47 | 209 | 2,397 | 38,171 | Feb 05, 2024, 05:15 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 02, 2024 | Sale | $28.49 | 209 | 5,954 | 37,962 | Feb 05, 2024, 05:15 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 26, 2024 | Sale | $25.38 | 26,017 | 660,370 | 47,566 | Jan 29, 2024, 05:54 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 26, 2024 | Option Exercise | $6.82 | 26,017 | 177,398 | 63,979 | Jan 29, 2024, 05:54 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 24, 2024 | Option Exercise | $8.04 | 11,300 | 90,822 | 49,262 | Jan 26, 2024, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 24, 2024 | Sale | $25.01 | 11,300 | 282,621 | 43,562 | Jan 26, 2024, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 25, 2024 | Option Exercise | $8.08 | 600 | 4,848 | 38,562 | Jan 26, 2024, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 25, 2024 | Sale | $25.00 | 600 | 15,000 | 38,262 | Jan 26, 2024, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 22, 2024 | Option Exercise | $10.34 | 34,166 | 353,359 | 72,128 | Jan 24, 2024, 04:50 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 22, 2024 | Sale | $22.62 | 34,166 | 772,691 | 66,712 | Jan 24, 2024, 04:50 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 23, 2024 | Option Exercise | $7.54 | 900 | 6,790 | 38,862 | Jan 24, 2024, 04:50 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 23, 2024 | Sale | $25.00 | 900 | 22,500 | 38,462 | Jan 24, 2024, 04:50 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,147 | 84,599 | 37,962 | Jan 09, 2024, 09:09 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2023 | Option Exercise | $4.17 | 2,956 | 12,327 | 26,606 | Feb 13, 2023, 05:02 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,130 | 11,243 | 15,599 | Mar 02, 2022, 06:22 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,473 | 14,921 | 12,624 | Feb 11, 2022, 04:39 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,702 | 18,399 | 7,380 | Mar 02, 2021, 07:25 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $0.76 | 14,060 | 10,643 | 26,990 | Jul 02, 2020, 06:15 PM |
Menu